Larry Corrigan serves as the Executive Director and Management Advisor for Commercial Insights and Analytics at TGaS Advisors, a division of Trinity, where he leverages his extensive experience in pharmaceutical commercial operations to drive impactful change for clients in the bio-pharmaceutical industry. With a distinguished...
Larry Corrigan serves as the Executive Director and Management Advisor for Commercial Insights and Analytics at TGaS Advisors, a division of Trinity, where he leverages his extensive experience in pharmaceutical commercial operations to drive impactful change for clients in the bio-pharmaceutical industry. With a distinguished career that includes leadership roles at notable organizations such as F2G, Aurinia, Spark, Shire, ViroPharma, and Wyeth, Larry has honed his expertise in strategic and tactical execution, consistently delivering actionable market intelligence and data-driven commercial strategies.
In his current role, Larry is instrumental in providing comprehensive benchmarking and advisory solutions tailored to the unique needs of commercial analytics leaders. He focuses on enhancing clients' commercial structures, optimizing operating practices, and refining resource planning and capabilities development. His ability to synthesize complex data into clear insights makes him a trusted advisor, guiding clients through critical decisions related to strategy, resource allocation, and process improvement.
Larry's skill set encompasses a wide array of competencies, including brand performance analysis, vendor management, and cross-functional team leadership. His proficiency in market research and sales operations enables him to deliver executive reporting that resonates with stakeholders, ensuring alignment across organizational goals. As he continues to lead key projects at TGaS Advisors, Larry remains committed to empowering clients with the insights necessary to navigate the dynamic pharmaceutical landscape, ultimately driving improved performance and sustainable growth.
